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Abstract
The implementation of new surgical techniques offers chances but carries risks. Usually, several years pass before a critical appraisal and a
balanced opinion of a new treatment method are available and rely on the evidence from the literature and expert’s opinion. The frozen
elephant trunk (FET) technique has been increasingly used to treat complex pathologies of the aortic arch and the descending aorta, but
there still is an ongoing discussion within the surgical community about the optimal indications. This paper represents a common effort of
the Vascular Domain of EACTS together with several surgeons with particular expertise in aortic surgery, and summarizes the current
knowledge and the state of the art about the FET technique. The majority of the information about the FET technique has been extracted
from 97 focused publications already available in the PubMed database (cohort studies, case reports, reviews, small series, meta-analyses
and best evidence topics) published in English.
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INTRODUCTION
A complex thoracic aortic pathology requires a simpliﬁed solution.
The conventional elephant trunk technique was introduced in 1983
and thereafter performed in a signiﬁcant number of patients world-
wide (Fig. 1). Later on, thoracic endovascular aortic repair (TEVAR)
broadened the armamentarium of the aortic surgeon to treat
several acute and chronic thoracic aortic diseases mainly located in
the distal aortic arch or in the descending aorta [1–4]. The logical
consequence was to bring both techniques (open surgery and
endovascular techniques) closer together to create a common plat-
form for a combined treatment, also called the ‘hybrid’ approach of
complex thoracic aortic pathology. As a step between the conven-
tional elephant trunk (cET) technique and the so-called frozen ele-
phant trunk (FET) technique, the combination of varying extents of
aortic arch replacement and antegrade TEVAR was practised until a
combined prosthesis became available (Fig. 2) [5, 6].
Following initial reports from Suto and Kato with home-made
combined grafts, the FET technique was popularized by Usui and
Karck, and is currently used to treat a variety of acute and chronic
thoracic pathologies (Fig. 3) [7–11].
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METHODS
Sources of information
Information on the FET technique have been extracted from 97
focused publications available in the PubMed database. Some of
these are cohort studies (N = 55), case reports (N = 19), reviews
(N = 10) and short series (N = 4), whereas others are meta-analyses
(N = 2) and best evidence topics (BET = 2) published in English.
Furthermore, four editorial commentaries have been collected as
they were requested by the journal Editors with regard to speciﬁc
submissions on the FET technique. One submission was published
as a letter to the Editor. The published articles include the major-
ity of patient cohorts available so far. The two available
meta-analyses included 2991 patients [12, 13]. A BET covered
two studies that included 230 cases [14]. Case reports, short
series and other articles take into account for over 4500 patients
operated on using the FET concept. Reports with less than 25
cases have been excluded. Finally, 40 studies include the vast
majority of the information published until now. It is to be noted
that some of these articles are sequential publications from
some centres, and may include patients from different eras [15–
53]. We support the recommendations for formulating and
issuing Guidelines and Expert Consensus Documents, which can
be found on the European Society of Cardiology website (http
://www.escardio.org and search for recommendations for guide-
lines production) (Tables 1 and 2).
Figure 1: Conventional elephant trunk technique.
Figure 2: Hemiarch replacement with antegrade TEVAR. TEVAR: thoracic endo-
vascular aortic repair.
Figure 3: Frozen elephant trunk technique.
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Countries, authors and centres
Several publications have been written by same authors since ex-
perience and information on the FET technique have usually
been produced by large-volume centres or those centres that
pioneered the usage of the FET technique. The countries where
information has been collected or drafted are the following:
Germany (N = 24), Japan (N = 20), Italy (N = 15), China (N = 12),
USA (N = 7), Austria (N = 4), Spain (N = 4), Greece (N = 3), UK
(N = 3) and Australia, Belgium, Finland, France and Switzerland
(N = 1 each).
The International E-Vita Open Registry (IEOR) is coordinated by
the West German Heart Center in Essen (Germany) and collected
cases from 11 centres of different European countries. It was insti-
tuted in 2006, and has produced the bulk of information on one
of the devices used up to now. The IEOR Group has published six
articles on the FET so far [23, 26, 28, 30, 31, 42]. The Collaborative
Research (CORE) Group, coordinated from Sydney, Australia and
the Attikon Hospital in Athens, Greece, have organized the two
meta-analyses on the FET [12, 13].
Dissemination of information
The appropriately sized case series articles, meta-analyses and
BETs have been published by the most prestigious peer-reviewed
journals in the ﬁeld of cardiothoracic surgery as follows: European
Journal of Cardiothoracic Surgery/Interactive Cardiovascular and
Thoracic Surgery (EJCTS/ICVTS—N = 16), The Journal of Thoracic and
Cardiovascular Surgery (JTCVS—N = 11), The Annals of Thoracic
Surgery (ATS—N = 6), Annals of Cardiothoracic Surgery (ACTS—
N = 6), The Journal of Cardiovascular Surgery (JCVS—N = 2), Annals
of Thoracic and Cardiovascular Surgery and Multimedia Manual of
Cardiothoracic Surgery (N = 1 each).
RESULTS
Preoperative diagnoses
The FET technique has been used in different aortic patholo-
gies, acute aortic dissection (Stanford Type A and B, DeBakey I),
atherosclerotic arch, descending or thoraco-abdominal aneur-
ysms and for other pathologies such as penetrating aortic
ulcers.
The published contributions do often present a broad mix of
diseases and it is not uncommon that authors refer simultan-
eously to ‘aortic dissection’ (either acute or chronic) when
dealing with Types A and B. Intrathoracic aneurysms are also
considered as an isolated condition including boundary territor-
ies such as the distal descending and thoraco-abdominal aorta.
On the other hand, there were some publications dealing only
with ‘acute dissection’, ‘chronic dissection’ and ‘atherosclerotic
aneurysm’.
Analysis of 40 series with more than 25 patients (range 25–
803) shows that the diagnosis of chronic dissection was present
in 6–73% of the cases in those papers in which all diagnostic cat-
egories were mixed. Acute aortic dissection was the initial path-
ology in 6–100% of the cases in articles dedicated to aortic
dissection.
The diagnosis of Type B and retrograde Type A dissection has
speciﬁcally been addressed in two contributions.
The frozen elephant trunk devices
Since the ﬁrst conception of FET, a number of devices have been
designed and used to achieve this complex procedure in one step.
The ﬁrst ones were home-made devices. Thereafter, several com-
panies have participated to the further technological evolution
and the following have been tested:
(i) Gianturco Z-stent (Cook®, Inc., Bloomington, USA).
(ii) Chavan-Haverich Prosthesis (Curative GmbH, Dresden,
Germany).
(iii) E-Vita Open and E-Vita Open Plus® ( Jotec® GmbH, Hechingen,
Germany).
(iv) Cronus™ (MicroPort Medical Co., Ltd, Shanghai, China).
(v) Thoraﬂex™ Hybrid Prosthesis (Vascutek®, Terumo®, Inchinnan,
Scotland, UK).
The described clinical outcomes have apparently not been sig-
niﬁcantly different with regard to the device used.
Table 2: Levels of evidence
Level of
evidence A
Data derived from multiple randomized clinical trials
or meta-analyses
Level of
evidence B
Data derived from a single randomized clinical trial
or large non-randomized studies
Level of
evidence C
Consensus of opinion of the experts and/small
studies, retrospective studies, registries
Table 1: Classes of recommendation
Definition Suggested wording to use
Class I Evidence and/or general agreement that a given treatment or procedure is beneficial, useful and effective Is recommended/is indicated
Class II Conflicting evidence and/or a divergence of opinion about the usefulness/efficacy of the given treatment or
procedure
Class IIa Weight of evidence/opinion is in favour of usefulness/efficacy Should be considered
Class IIb Usefulness/efficacy is less well established by evidence/opinion May be considered
Class III Evidence or general agreement that the given treatment or procedure is not useful/effective and in some
cases may be harmful
Is not recommended
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Intraoperative details: complexity
In general, authors disclosed intraoperative details that are consid-
ered to give the reader an idea of the complexity of this type of
surgery. It is well agreed that the FET technique is part of a
complex and demanding procedure. This becomes evident when
the duration of the operation, cardiopulmonary bypass time
and the length of the period of cerebral perfusion are considered.
Cardiopulmonary bypass and myocardial protection are well-
established concepts that do not need further discussion.
Hypothermic circulatory arrest together with cerebral protection
(in the large majority of cases in an antegrade way) will not be dis-
cussed further. Surprisingly, the duration of lower body and ab-
dominal ischaemia is usually not addressed. Rough data from the
series published indicate that the following information are
welcome:
(i) Cardiopulmonary bypass.
(ii) Cardiac ischaemia.
(iii) Circulatory arrest (with/without antegrade cerebral perfusion).
Early postoperative complications
The most frequent postoperative complications refer to the need
for postoperative re-exploration because of bleeding, stroke,
spinal cord injury (SCI) and acute kidney injury (AKI) requiring
dialysis. For the last three complications, either transient and per-
manent deﬁcits or requirements are considered. They are sum-
marized in Table 3.
The main problem with the description of postoperative out-
comes is the lack of uniformity in reporting and the broad mix of
complications. Aggregate outcomes (SCI—AKI) may give a better
view of the complexity of the procedure on the general health
condition of the patients.
The review of the available publications conﬁrms that the major
problem with the FET technique is SCI that includes paraplegia
and paraparesis. There is no mention in any of the articles pub-
lished so far about the diagnosis and evolution of paraparesis,
which is supposed to be a less devastating step of SCI. It seems
that SCI tends to happen preferentially in patients operated on for
chronic dissection, but this ﬁnding is not easy to conﬁrm due to
the way it is reported in the different articles.
Follow-up
The major interest in reporting of follow-up concerns the evalu-
ation of the patency of the false lumen in the case of dissection
and complete exclusion without endoleaks after aneurysm repair.
There are large differences in reporting follow-up timings. Other
than 1-year survival, different teams report at different intervals
(3-, 4-, 5-, 8- and 10-year) according to the individual team ex-
perience. The average reported follow-up in months is 26.3 (range
3–104). There are only few data with a follow-up at 10 post-
operative years. The average reported survival rates at 1, 3 and 5
years are 87, 78 and 68%, respectively.
The most beneﬁcial effect of FET is the promotion of early false
lumen thrombosis in patients treated because of acute aortic dissec-
tion. The average rate of early (<3 months) false lumen thrombosis
at the level of the stent-graft as assessed by imaging techniques
(computed tomography or magnetic resonance) is 85% (range 69–
100%). Moreover, it increases to 89% within 6–12 months after
surgery. These data conﬁrm that aortic remodelling starts immedi-
ately after surgery and progresses over time.
Secondary interventions
Since most series dealing with this topic merge open surgical and
endovascular completion, it is difﬁcult to extract objective infor-
mation. On top of that, series encompass mixtures of pathologies
(dissection versus non-dissection), variable extends of aneurysms
(purely thoracic versus thoraco-abdominal) and mixtures of
frozen and free-ﬂoating elephant trunks.
Limitations of reporting outcomes in the current
literature
There are a number of limitations in reporting outcomes of the
FET technique that are summarized as follows:
(i) Individual institutional experiences.
(ii) With few exceptions, every single contribution is a retro-
spective analysis of a departmental database.
(iii) Retrospective design.
(iv) Usually small size of the series (corresponds to the rarity of
the pathology).
(v) Lack of uniformity in surgical methodology.
(vi) Lack of uniformity in reporting.
(vii) Heterogeneity of populations (mostly based on age groups).
(viii) Potential differences according to the device used.
DISCUSSION
The FET technique has broadened the armamentarium of surgeons
and simpliﬁed the treatment of complex thoracic aortic patholo-
gies. The conceptual strategy to obtain the most complete
primary repair possible and to provide concomitant circum-
stances that facilitate any secondary future intervention is effect-
ive. However, this procedure may be performed at the cost of a
signiﬁcant adverse event that is a higher rate of SCI. Further
Table 3: Aggregate morbidity and mortality
Reop
bleeding
Stroke SCI (paraplegia + paraparesis) AKI (aggregate transient + permanent dialysis) Laryngeal
nerve palsy
In-hospital mortality
(30 days—no discharge)
2.5–30% 2.5–20% 0–21% 4–34.8% 0–12.8% 1.8–17.2%
SCI: spinal cord injury; AKI: acute kidney injury.
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experience and research will better clarify the mechanisms of SCI
and help to reduce its incidence.
Indications
It remains challenging to deﬁne robust indications for the FET
technique and consequently recommendations for use. However,
several preoperative diagnoses may apply for the technique.
Acute type A aortic dissection
There are most probably two main issues that should be consid-
ered when FET is used in acute type A aortic dissection being (i)
FET may be an ideal technique to treat complications due to mal-
perfusion since it helps to expand the true lumen in the proximal
part of the descending aorta and thereby to close some of the
communications between the lumina at this level and (ii) FET may
help to prevent future events (mainly aneurysm formation in the
chronically dissected descending aorta). Visceral and renal mal-
perfusion are frequently associated with an entry tear in the distal
aortic arch or the proximal descending aorta [54]. Consequently,
replacement of the ascending aorta with a distal anastomosis at
the level of the proximal or mid-aortic arch will not re-establish
regular antegrade ﬂow conditions to resolve malperfusion due to
true lumen compression. To achieve this result, more extensive
repair is needed and the FET technique represents an ideal mo-
dality to ﬁx the problem [55]. Figure 4 shows morphology in a case
in which a primary entry tear in the proximal descending aorta is
associated with visceral and renal malperfusion. Preventing post-
dissection aneurysm formation is attractive as secondary surgical
repair may be challenging and secondary endovascular repair is
not always feasible. In acute type A aortic dissection, the indica-
tion to proceed with FET has to balance the risk of a more
demanding procedure against the mid-term beneﬁts of it. In this
emergency situation, survival of the patient is the ﬁrst and fore-
most important goal and a later operation under optimal condi-
tions may carry a low risk when performed in an experienced
aortic centre [23, 26, 28].
Post-dissection aneurysmal formation after type A
repair
The use of the FET technique is reported for the treatment of post-
dissection aneurysmal formation after type A repair [21, 24, 30, 31].
In this case, the following aspects must be considered (i) the loca-
tion of the segment with the maximal diameter—the more prox-
imal, the higher the likelihood of effectiveness (ii) the size of the
true lumen, which is often very narrowed because there is still a
risk for pseudocoarctation after FET implantation. It should be the
aim of future investigations to deﬁne the minimal size for the true
lumen to avoid this complication. Furthermore, similar challenges
may arise as in TEVAR for aneurysmal formation after type B aortic
dissection, which is an incomplete expansion of the true lumen
due to the rigidity of the dissection membrane, reperfusion of the
false lumen from any distal communication between both lumina
and membrane rupture at the distal end of the stent-graft due to
counteracting forces between the self-expanding characteristic of
the stent-graft and the relatively rigid chronic dissection mem-
brane [56–58]. Figure 5 shows a scenario after ascending/hemiarch
replacement where aneurysm formation occurred due to a per-
sistently patent primary entry tear in the distal aortic arch amend-
able to the FET technique.
Acute type B aortic dissection
TEVAR is the treatment of ﬁrst choice in patients with complicated
acute type B aortic dissection, and recently has been recommended
for patients with uncomplicated type B aortic dissection as well
because TEVAR is associated with improved 5-year aortic-speciﬁc
survival and delayed disease progression [59, 60]. However, the
issue of retrograde type A aortic dissection remains unsolved and
patients undergoing TEVAR for type B aortic dissection remain at a
substantially increased risk. Factors associated with retrograde
type A aortic dissection after TEVAR have been identiﬁed, but
there is still a grey zone [61, 62]. Consequently, the FET technique
represents an alternative to primary TEVAR and its effectiveness
has already been reported [50]. Figure 6 shows morphology of a
complicated type B aortic dissection where the FET technique
Figure 4: Primary entry tear in the proximal descending aorta associated with
visceral and renal malperfusion.
R
EP
O
R
T
M. Shrestha et al. / European Journal of Cardio-Thoracic Surgery 763
should be considered when there is no landing zone for TEVAR,
the aortic arch is dilated or the arch angulation is steep.
Post-dissection aneurysmal formation after chronic
type B aortic dissection
In this category, similar principles apply as in acute type B aortic
dissection where the challenges regarding long-term durability
are similar to those after FET implantation for post-dissection an-
eurysmal formation after type A repair.
Thoracic aortic aneurysms
Any type of thoracic aortic aneurysm that otherwise would
require a surgical two-step approach may qualify for the FET tech-
nique, but it remains a strategic choice if primary distal seal is
intended or secondary retrograde TEVAR for completion is chosen
in order to reduce the potential risk of symptomatic SCI by
priming the collateral network [63]. FET qualiﬁes for both, second-
ary open and endovascular repair because the nitinol frame of the
stent-graft well tolerates clamping and resumes its natural conﬁg-
uration after declamping due to the inherent memory effect of
the alloy [64].
Penetrating atherosclerotic ulcers/intramural
haematomas
Also here the extent of the disease indicates the choice of the pro-
cedure. In particular, in patients with penetrating atherosclerotic
ulcers (PAUs) as an aggressive underlying obliterative disease
process, have an increased risk of stroke and embolism and may
be candidates for the FET procedure [65]. In patients with intra-
mural haematoma of the entire thoracic aorta where an entry tear
in the distal aortic arch or the descending aorta can be localized,
the FET technique may serve as an ideal procedure to ﬁx the
entire thoracic aortic pathology [66]. Figure 7 shows a clinical case
where multiple PAUs affect the entire thoracic aorta where the
FET technique is applicable.
Devices currently used in Europe
Two devices are widely used in Europe: E-Vita Open and E-Vita Open
Plus® ( Jotec® GmbH, Hechingen, Germany) and the Thoraﬂex™
Figure 6: Complicated type B aortic dissection without a landing zone for
TEVAR, due to an ectatic aortic arch suitable for the FET technique.
Figure 5: Scenario after ascending/hemiarch replacement with aneurysm for-
mation due to a persistently patent primary entry tear in the distal aortic arch
amendable to the FET technique.
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Hybrid Prosthesis (Vascutek®, Terumo®, Inchinnan, Scotland, UK).
Both techniques are shown in Figs 8 and 9. In the literature, there
are no major differences between the two systems regarding the
primary outcome parameters. However, because of their different
designs, the choice of the device may differ according to the indi-
vidual strategy required in each speciﬁc case. The main difference
is the provision of a quadruple branched Dacron® part with the
Vascutek® system when compared with a straight Dacron® part
with the Jotec® device. Both prostheses currently are distributed
with a sewing cuff at the transition between the Dacron® part and
the stent-graft to facilitate the descending aortic anastomosis. The
quadruple branched design of the Vascutek® prosthesis enables a
more proximal descending aortic anastomosis (between the left
common carotid and the left subclavian arteries) since the left sub-
clavian artery can be re-attached to the prosthesis using the most
distal branch of the device. Regarding long-term performance of
the stent-graft portion, there is no information available so far.
Hypothermic circulatory arrest and cerebral
protection strategy
Cerebral protection strategies have been continuously modiﬁed
during the last decade and the routine use of deep hypothermic
circulatory arrest as isolated protection strategy is no more rou-
tinely used in Europe. Several publications including a recent
survey upon the current trends of neuroprotection during surgery
for acute type A aortic dissection in Europe show safety, efﬁcacy
as well as the broad implementation of milder hypothermic circu-
latory arrest temperatures in combination with the routine appli-
cation of selective antegrade cerebral perfusion as an increasingly
used strategy to optimize brain and end-organ protection [67, 68].
Consequently, the 2014 ESC guidelines on the diagnosis and treat-
ment of aortic diseases recommend antegrade selective cerebral
perfusion during hypothermic circulatory arrest to reduce the
stroke risk during aortic arch surgery (Class IIa, Level B) [60]. In
addition, some degree of spinal cord blood supply is provided as
well by antegrade selective cerebral perfusion.
Figure 8: Scheme of frozen elephant trunk (FET) implantation with the Jotec
device using an island technique when reimplanting the supra-aortic vessels.
Figure 7: Multiple penetrating atherosclerotic ulcers (PAUs) affecting the entire
thoracic aorta where the FET technique is applicable.
Figure 9: Scheme of FET implantation with the Vascutek device using a sepa-
rated reimplantation of the supra-aortic vessels.
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Neurological injury: paraplegia after conventional
and frozen ET (cET versus FET)
SCI is one of the most devastating complications after extensive
thoraco-abdominal aortic surgery, but particularly shattering after
primary aortic arch repair. Paraplegia has been rarely reported
after cET surgery. The reported incidence rate of permanent or
transient ischaemic SCI after cET implantation ranges between 0.4
and 2.8% [69–71]. In contrast, the reported incidence rate of SCI in
patients undergoing FET appears to be signiﬁcantly higher. Data
from the IEOR on 274 FET patients revealed an 8% rate of SCI, and
a recent multicentre study reported a 9% incidence rate of this
dreaded complication [28, 31].
Single-centre studies have reported incidences as high as 21–
24% after FET implantation and hypothesized various mechanisms
to explain SCI [16, 72, 73]. Miyairi et al. [72] attributed their
observed episodes of post-FET paraplegia to spinal cord ischaemic
times longer than 60 min in 3 of 4 cases, and unstable haemo-
dynamics after cardiopulmonary bypass may have played an ag-
gravating role. Mizuno et al. [73] reported 2 cases of paraplegia in
their series of 9 FET patients without any identiﬁable risk factor,
but their average lower body arrest time was long (54 ± 10 min). In
both cases of paraplegia, the distal circulatory arrest time was
longer than 40 min. One of the factors that may have an impact
on SCI is the level of the distal landing zone of the stent-graft: the
more distally the FET is deployed, the higher the number of
occluded intercostal arteries. Flores et al. [16] demonstrated that a
distal landing zone beyond T7 is associated with a signiﬁcantly
higher incidence of SCI. He reported a 24% incidence (6 of 25
patients) of ischaemic SCI in their series and distal deployment of
the stent-graft was a signiﬁcant risk factor in multivariate analysis.
Similarly, Mizuno et al. [73] reported that the distal landing zone
was at the T8 level in both patients suffering postoperative para-
plegia. Thromboembolism to the spinal cord in the presence of
severe atherosclerosis at the distal landing zone of the stent-graft
is another potential mechanism of SCI [16].
Interestingly, the combination of a distal landing zone of T7 or
lower and a history of previous abdominal aortic aneurysm repair
was the strongest predictor for SCI in the Flores series [16]. This ob-
servation suggests an important role of distal inﬂow to the paraspinal
arterial collateral network via the hypogastric arteries. Recent experi-
mental studies on spinal cord blood ﬂow, however, suggest that
spinal perfusion is not acutely compromised by serial segmental
artery sacriﬁce in a cranio-caudal direction down to a level of T11/
12. Such ﬁndings are supported by the reasonably low paraparesis
or paraplegia rates of 3.8% in clinical series of descending thoracic
and Crawford type I thoraco-abdominal aortic aneurysm repairs [74].
The collateral network concept by Etz and Griepp has been
used to explain this phenomenon [63, 71, 75]. FET procedures,
however, have the potential to impact on both inﬂow pathways
simultaneously: segmental artery perfusion and upper inﬂow to
the collateral network via the vertebral artery. This might be one
reason for the increased occurrence of paraplegia and the signiﬁ-
cantly higher incidence when compared with cET procedures.
Follow-up and secondary interventions
It is obvious that patients after FET implantation warrant a similar
follow-up protocol as patients after TEVAR do. Similarly to what
may happen following primary TEVAR, there may be need for
planned or unplanned secondary intervention, open or
endovascular. A comparison between open surgical completion
and endovascular completion after cET has been reported by the
Cleveland Clinic [76]. Open surgical completion is more demand-
ing and represents a major intervention for the patient but is
more durable [76]. In summary, there is a greater need for transfu-
sion (red blood cells, plasma and platelets), an increased need for
prolonged ventilation (requiring tracheostomy in certain patients)
and an overall longer duration of hospital stay in the open comple-
tion group compared with the endovascular group. No difference
was found between renal failure and neurological complications
between both groups. Endoleaks occurred in 35% of the endovas-
cular completion group. This becomes also obvious from the series
of Greenberg et al. [77]. The 30-day mortality rate did not differ
between the open surgical completion and the endovascular com-
pletion: 6 vs 6.5%, respectively.
Future developments
It is obvious that currently available devices have certain limitations
and need continuing modiﬁcations. It is likely that, in the near
future, simpliﬁed devices will be available making deployment and
ﬁxation comparable with a simple hemiarch replacement. Current
modiﬁcations may include shorter versions of original devices.
These developments may help to broaden the applicability and the
acceptance of the method. In December 2013, the National
Institute for Health and Care Excellence in the United Kingdom
(NICE) has accredited the use of the FET concept for the treatment
of complex aneurysms and dissections of the aorta by approving
the use of a speciﬁc commercially available device (www.guidance.
nice.org.uk/mtg16). This may help in enhancing applicability as
mentioned. In any case, future intensive research will induce
broader implementation of this technique or put it into question.
Data collection and reporting standards
We strongly support broad data collection, in particular, as sub-
stantial need for increased knowledge concerning several aspects
of the procedure such as SCI remains. There is one registry report-
ing the results after FET using the E-Vita Open® prosthesis (IEOR).
To date, there is no registry reporting the results after FET using
the Thoraﬂex™ prosthesis.
Reporting standards create a common language and a platform
for knowledge exchange and are therefore strongly needed. The
following suggestions are made addressing intraoperative para-
meters during the FET procedure: arterial cannulation site, core
temperature during hypothermic circulatory arrest, type of cere-
bral perfusion, perfusate temperature and ﬂow, cerebral perfusion
time and hypothermic circulatory arrest time. In addition, the mo-
dality of cerebral monitoring, cardiopulmonary bypass time and
myocardial ischaemic time should be reported.
A clear separation between lower body hypothermic circulatory
arrest and cerebral hypothermic circulatory arrest should be
made. In case of lower body perfusion, type and cannulation site,
perfusate temperature as well as ﬂow should be reported. Regarding
the prosthesis, length and diameter of the stented portion should be
reported.
Regarding procedure-related outcome, stroke and SCI as well as
their suspected pathophysiological mechanisms should be reported
in detail. Regarding reporting of follow-up parameters, we suggest
adhering to recent EACTS/ESC recommendations [78]. Secondary
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interventions, open or endovascular, should be reported. Finally,
survival and aortic-related survival should be clearly differentiated.
Recommendation for use
Based on the available literature and on the expert consensus opinion
of the authors, the following recommendations can be made:
(i) The FET technique or an alternative method to close the
primary entry tear should be considered in patients with
acute type A aortic dissection with a primary entry in the
distal aortic arch or in the proximal half of the descending
aorta to treat associated malperfusion syndrome or to avoid
its postoperative development. Class of recommendation IIa
—Level of evidence C [23, 55]
(ii) The FET technique may be considered for use in patients
undergoing surgery for acute type A aortic dissection to
prevent mid-term aneurysmal formation in the downstream
aorta. Class of recommendation IIb—Level of evidence C
[19, 47–49]
(iii) The FET technique should be considered in patients with com-
plicated acute type B aortic dissection when primary TEVAR is
not feasible or the risk of retrograde type A aortic dissection is
high. Class of recommendation IIa—Level of evidence C [50]
(iv) The FET technique should be considered in patients with ex-
tensive thoracic or thoraco-abdominal aortic disease when a
second procedure, either open surgical or endovascular in
downstream aortic segments, can be anticipated. Class of rec-
ommendation IIa—Level of evidence C [42, 64]
Summary
The FET technique has broadened the armamentarium of sur-
geons and simpliﬁed the treatment of complex thoracic aortic
pathology. The concept of obtaining the most possible complete
primary repair and facilitating any secondary future intervention is
effective. However, a trade-off regarding a higher rate of SCI is a
serious problem. Further research will hopefully clarify the
mechanisms of symptomatic SCI, and help to reduce its incidence.
Conﬂict of interest: Heinz Jakob is a consultant with Jotec.
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